What is early perimenopause?
Perimenopause is the transitional phase before menopause, during which oestrogen and progesterone levels begin to fluctuate and decline. Early perimenopause refers to perimenopause that begins before the typical age range — most commonly used to describe onset before 45, and sometimes specifically before 40.
The term covers a spectrum:
| Age at onset | Classification | Prevalence | Key considerations |
|---|---|---|---|
| Before 40 | Premature ovarian insufficiency (POI) | ~1% of women | Requires investigation; specific long-term health implications |
| 40–44 | Early perimenopause | ~10% of women | Often misdiagnosed; clinical diagnosis possible with symptoms |
| 45–47 | Earlier than average | ~30% of women | NICE supports clinical diagnosis without blood tests over 45 |
| 47–51 | Average onset | ~45% of women | Most common range |
| 51+ | Later onset | ~14% of women | Normal variation; no specific concern |
This page focuses primarily on perimenopause in the early-to-mid 40s — the group most likely to go undiagnosed and untreated for the longest time.
Early perimenopause (ages 40–44) and premature ovarian insufficiency (before 40) are different conditions with different management pathways. If you are under 40 and experiencing perimenopause-like symptoms, specific investigation is important — see your GP rather than assuming natural perimenopause.
Early perimenopause symptoms
The symptoms of early perimenopause are the same as perimenopause at any age — the hormonal changes are identical, just occurring earlier. The challenge is that in your early 40s, these symptoms are routinely attributed to other causes.
The earliest signs most women notice first
In early perimenopause, the initial hormone to decline is typically progesterone (not oestrogen). This creates a characteristic pattern of symptoms driven by oestrogen dominance relative to progesterone, rather than the low-oestrogen symptoms that come later:
- Periods becoming heavier or longer
- Worsening PMS — more intense than before
- Increased breast tenderness before periods
- More bloating in the premenstrual week
- Shorter cycles (e.g. 28 days becoming 24–25)
- Heightened anxiety, particularly premenstrually
- Night sweats — particularly in the week before a period
- Sleep becoming less restorative
Later early perimenopause symptoms
As oestrogen levels begin to fluctuate more widely (rather than just decline), more of the classic perimenopause symptoms emerge:
- Hot flushes (may be mild initially)
- Night sweats not linked to menstrual cycle
- Irregular periods — cycles varying in length
- Brain fog and difficulty concentrating
- Unexplained fatigue
- Low mood or increased emotional sensitivity
- Anxiety that feels different or worse than before
- Joint aches and pains
- Vaginal dryness (often later in perimenopause)
- Reduced libido
- Heart palpitations
- Dry skin or changes in skin texture
Research suggests women in their early 40s wait an average of 2–4 years between first experiencing perimenopause symptoms and receiving a diagnosis. Common misdiagnoses include anxiety disorder, depression, thyroid dysfunction, and burnout. If you are 40–44 and experiencing several of the above symptoms — particularly in combination with cycle changes — perimenopause deserves to be on the differential.
Early perimenopause at 40, 41, 42, 43, 44
Perimenopause beginning in the early 40s is an increasingly recognised pattern. Here's what to expect and consider at each stage:
Perimenopause at 40–41
At this age, symptoms most often begin with the progesterone-deficiency pattern described above: worsening PMS, heavier periods, increasing anxiety and sleep disruption. Hot flushes may be absent entirely at this stage, which is one reason the diagnosis is missed — many women (and doctors) don't consider perimenopause without hot flushes.
For women aged 40–44, NICE guidelines recommend hormonal blood tests (FSH, LH, oestradiol) to support diagnosis, as symptoms alone are less specific at this age. However, a single blood test is unreliable — hormone levels fluctuate significantly. A clinical picture supported by multiple tests is more informative.
Contraception is still important. Being in early perimenopause does not mean you cannot get pregnant. Ovulation continues, just unpredictably. Contraception is recommended until you have had 12 months without a period (if you're over 50) or 24 months without a period (if you're under 50).
Perimenopause at 42–43
Oestrogen fluctuations typically become more pronounced in the mid-40s. This is when the full range of perimenopause symptoms tends to emerge — hot flushes, night sweats, brain fog and mood changes joining the earlier cycle and PMS disruptions. At this point, the symptom picture is more recognisably perimenopausal.
Women in this age group may find that lifestyle factors they previously tolerated — poor sleep, alcohol, stress — now significantly worsen symptoms. This is because oestrogen fluctuations amplify the body's stress response and disrupt sleep architecture in ways that compound each other.
Perimenopause at 44–45
By 44, a clinical diagnosis of perimenopause based on symptoms is increasingly supported without blood tests. Periods may become noticeably irregular — cycles lengthening or shortening unpredictably, or periods becoming lighter as ovarian activity declines. This is typically when women begin to make the connection themselves between their symptoms and perimenopause.
What causes early perimenopause?
Most early perimenopause is simply natural variation — the same biological process occurring at the lower end of the normal age range. However, several factors are known to bring perimenopause onset forward:
Genetics
Your mother's menopause age is the strongest single predictor of yours. If your mother had an early menopause (before 47), your risk of early perimenopause is significantly elevated. Genetics accounts for an estimated 50–80% of the variation in menopause timing.
Smoking
Smoking accelerates ovarian ageing. Smokers reach menopause an average of 1–2 years earlier than non-smokers, with the effect being dose-dependent. A woman who smokes heavily and has a family history of early menopause may experience perimenopause onset several years earlier than she would otherwise expect. The toxic compounds in cigarette smoke damage ovarian follicles and accelerate depletion of the ovarian reserve.
Previous medical treatments
Certain cancer treatments — particularly alkylating chemotherapy agents (such as cyclophosphamide) and pelvic or whole-body radiotherapy — can cause ovarian damage that leads to early menopause. Women who have had these treatments should be aware of this risk and seek monitoring if they develop symptoms.
Autoimmune conditions
Some autoimmune conditions, including thyroid autoimmunity and adrenal autoimmunity, are associated with a higher risk of premature ovarian insufficiency. This is particularly relevant if you have another autoimmune condition and develop perimenopause symptoms before 40.
Turner syndrome and chromosomal differences
Women with Turner syndrome (45,X karyotype) or mosaic Turner syndrome typically experience premature ovarian insufficiency. This is usually identified earlier in life, but some mosaic forms may not be diagnosed until a woman presents with early menopause symptoms.
Low body weight
Very low body fat percentage — common in endurance athletes or women with a history of restrictive eating — can affect ovarian function. Adipose tissue is a secondary source of oestrogen, and very low body fat reduces this contribution. Significant caloric restriction over time may also affect hypothalamic-pituitary-ovarian signalling.
The majority of women who experience perimenopause in their early 40s have no identifiable underlying cause — it is simply the earlier end of normal variation. You do not need to have a risk factor for early onset. However, if you have symptoms before 40, investigation is important to rule out conditions that require specific management.
Getting a diagnosis of early perimenopause
Diagnosis in women aged 40–44 is more complex than in women over 45, because symptoms are less specific and hormone levels more variable.
What your GP should do
For women aged 40–44 with symptoms suggestive of perimenopause, NICE guidelines recommend:
• FSH blood test — elevated FSH (typically >10–12 IU/L, but labs vary) supports a diagnosis. However, FSH fluctuates significantly in perimenopause, so a single normal result does not rule it out. Ideally two tests 4–6 weeks apart are needed.
• Oestradiol — variable; can be low, normal or high depending on where you are in your cycle. More useful in combination with FSH than alone.
• AMH (anti-Müllerian hormone) — a marker of ovarian reserve. Low AMH at 40–44 is consistent with perimenopause and can provide supporting evidence. Not routinely available on the NHS but available privately.
• Thyroid function — thyroid dysfunction can mimic many perimenopause symptoms. Should be checked to rule out as a contributor.
What if blood tests are "normal"?
Many women in early perimenopause have blood tests that fall within the normal range — because hormones fluctuate so widely. A normal FSH on one day does not mean you are not in perimenopause. The clinical picture (your symptoms, your cycle changes, your family history) matters enormously. If your GP dismisses the diagnosis based solely on a normal blood test, it is entirely reasonable to request repeat testing or a referral to a menopause specialist.
Seeking a menopause specialist
If you are struggling to get a diagnosis or treatment via your GP, you have several options:
NHS menopause clinics — available via GP referral in most areas. Often have shorter waiting times since the expansion of NHS menopause services from 2023.
Private menopause clinics — British Menopause Society (BMS) and Menopause Matters both maintain directories of accredited specialists. Consultations typically cost £150–250 but provide specialist input where GP support has been limited.
Treatment options for early perimenopause
The treatment options for early perimenopause are the same as for perimenopause at any age — but there is an additional consideration: women who experience perimenopause before 45 have a longer period of reduced oestrogen exposure ahead of them, which has implications for long-term bone and cardiovascular health.
HRT in early perimenopause
Hormone replacement therapy (HRT) is the most effective treatment for perimenopausal symptoms. In women under 45, there is an additional argument for HRT beyond symptom management: oestrogen has protective effects on bone density and cardiovascular health, and early perimenopause means a longer period of reduced oestrogen if untreated.
NICE guidelines specifically recommend that women with premature ovarian insufficiency (POI, before 40) take HRT until at least the average natural menopause age of 51, to protect bone density and cardiovascular health. This same logic is often extended — and many menopause specialists would support it — to women experiencing perimenopause in their early 40s.
For women in their early 40s who are not yet postmenopausal:
• Combined HRT (oestrogen + progesterone) is typically recommended if you still have a uterus
• Body-identical HRT — oestradiol patches/gel + micronised progesterone (Utrogestan) — is the preferred option, particularly in younger women, because of the best safety and tolerability profile
• Contraception still needed — HRT does not provide contraception. If pregnancy is not desired, a Mirena IUS (hormonal coil) can serve the dual function of providing the progestogen component of HRT and offering contraception
Non-hormonal approaches
For women who cannot or choose not to take HRT, evidence-based non-hormonal options include:
CBT — cognitive behavioural therapy adapted for menopause (CBT-M) has good evidence for reducing the distress associated with hot flushes and improving mood and sleep. Available via NHS IAPT in some areas.
SSRIs/SNRIs — venlafaxine, fluoxetine and escitalopram can reduce hot flush frequency. Typically less effective than HRT but useful for women with contraindications.
Exercise — regular aerobic exercise reduces symptom severity and has evidence for improving mood, sleep and cognitive function in perimenopause. Resistance training is particularly important in early perimenopause to protect muscle mass and bone density during the years ahead.
Sleep and stress management — perimenopause sleep disruption and anxiety often form a reinforcing cycle. Breaking this cycle — through sleep hygiene, CBT-I, or HRT — has downstream benefits across multiple symptoms.
Is perimenopause affecting your body age?
Hormonal changes can accelerate biological ageing across your heart, bones and metabolism. Get a personalised report.
▶ Get My Personalised Body Age ReportEarly perimenopause and long-term health
One aspect of early perimenopause that deserves more attention is its implications for long-term health — beyond the immediate symptom burden.
Bone density
Oestrogen is the primary regulator of bone remodelling in women. The rate of bone loss accelerates in perimenopause and the years following menopause. Women who experience early perimenopause have a longer window of reduced oestrogen and therefore a greater cumulative risk of bone density loss and osteoporosis over a lifetime. This is a key reason why HRT (or adequate calcium and vitamin D, and weight-bearing exercise as a minimum) matters more — not less — for women with early perimenopause.
Cardiovascular health
Oestrogen has multiple cardioprotective effects — on lipid profiles, arterial elasticity and inflammatory pathways. Before menopause, women have lower cardiovascular risk than men of the same age; after menopause, this advantage narrows progressively. Earlier menopause is associated with modestly higher cardiovascular risk over a lifetime. The "window of opportunity" for cardiovascular benefit from HRT — where starting HRT within 10 years of menopause confers protective effects — is particularly relevant for women with early onset.
Cognitive health
Emerging evidence suggests that oestrogen has neuroprotective effects, and that the hormonal changes of perimenopause may affect cognitive function in the transition period. Women often report brain fog and memory difficulties during perimenopause, which typically improve after the transition. Earlier perimenopause means an earlier start to this period of hormonal cognitive disruption, though long-term effects remain an area of active research.